Some of the tumour infiltrating cells, e.g., CD4+, CD335+ cells, were increased in the tumours of all responding mice, whereas CD8+, CD141+ were increased and CD11b+ cells were decreased preferentially in R-115-treated mice. The gene discussed is NCR1; the disease is neoplasm.